|
1
|
Thompson L: World Health Organization
classification of tumours: Pathology and genetics of head and neck
tumours. Ear Nose Throat J. 85:742006.PubMed/NCBI
|
|
2
|
Hertog D, Bloemena E, Aartman IHA and
van-der-Waal I: Histopathology of ameloblastoma of the jaws; some
critical observations based on a 40 years single institution
experience. Med Oral Patol Oral Cir Bucal. 17:e76–e82. 2012.
View Article : Google Scholar :
|
|
3
|
Reichart PA, Philipsen HP and Sonner S:
Ameloblastoma: Biological profile of 3677 cases. Eur J Cancer B
Oral Oncol. 31B:86–99. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hong J, Yun PY, Chung IH, Myoung H, Suh
JD, Seo BM, Lee JH and Choung PH: Long-term follow up on recurrence
of 305 ameloblastoma cases. Int J Oral Maxillofac Surg. 36:283–288.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sandra F, Hendarmin L, Kukita T, Nakao Y,
Nakamura N and Nakamura S: Ameloblastoma induces
osteoclastogenesis: A possible role of ameloblastoma in expanding
in the bone. Oral Oncol. 41:637–644. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hirshberg A, Shnaiderman-Shapiro A, Kaplan
I and Berger R: Metastatic tumours to the oral cavity -
pathogenesis and analysis of 673 cases. Oral Oncol. 44:743–752.
2008. View Article : Google Scholar
|
|
7
|
Jimi E, Shin M, Furuta H, Tada Y and
Kusukawa J: The RANKL/RANK system as a therapeutic target for bone
invasion by oral squamous cell carcinoma (Review). Int J Oncol.
42:803–809. 2013.PubMed/NCBI
|
|
8
|
Casimiro S, Mohammad KS, Pires R,
Tato-Costa J, Alho I, Teixeira R, Carvalho A, Ribeiro S, Lipton A,
Guise TA, et al: RANKL/RANK/MMP-1 molecular triad contributes to
the metastatic phenotype of breast and prostate cancer cells in
vitro. PLoS One. 8:e631532013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Souza Freitas V, Ferreira de Araújo CR,
Alves PM, de Souza LB, Galvão HC and de Almeida Freitas R:
Immunohistochemical expression of matrilysins (MMP-7 and MMP-26) in
ameloblastomas and adenomatoid odontogenic tumors. Oral Surg Oral
Med Oral Pathol Oral Radiol Endod. 108:417–424. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ribeiro BF, Iglesias DPP, Nascimento GJF,
Galvão HC, Medeiros AM and Freitas RA: Immunoexpression of MMPs-1,
-2, and -9 in ameloblastoma and odontogenic adenomatoid tumor. Oral
Dis. 15:472–477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang B, Zhang J, Xu ZY and Xie HL:
Expression of RECK and matrix metalloproteinase-2 in ameloblastoma.
BMC Cancer. 9:4272009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qian Y and Huang HZ: The role of RANKL and
MMP-9 in the bone resorption caused by ameloblastoma. J Oral Pathol
Med. 39:592–598. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen LC, Chen YK, Hsue SS and Shaw SY:
Expression of osteonectin/secreted protein acidic and rich in
cysteine and matrix metalloproteinases in ameloblastoma. J Oral
Pathol Med. 39:242–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Henriques ÁCG, Vasconcelos MG, Galvão HC,
de Souza LB and de Almeida Freitas R: Comparative analysis of the
immunohistochemical expression of collagen IV, MMP-9, and TIMP-2 in
odontogenic cysts and tumors. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod. 112:468–475. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sharma M, Sah P, Sharma SS and
Radhakrishnan R: Molecular changes in invasive front of oral
cancer. J Oral Maxillofac Pathol. 17:240–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Whitehouse GH: Radiological bone changes
produced by intraoral squamous carcinomata involving the lower
alveolus. Clin Otolaryngol Allied Sci. 1:45–52. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Murrin RJA and Mahendra P: ‘Floating’
teeth at presentation in sporadic Burkitt's lymphoma. Br J
Haematol. 127:12004. View Article : Google Scholar
|
|
18
|
Harada H, Mitsuyasu T, Nakamura N, Higuchi
Y, Toyoshima K, Taniguchi A and Yasumoto S: Establishment of
ameloblastoma cell line, AM-1. J Oral Pathol Med. 27:207–212. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sweeney RT, McClary AC, Myers BR, Biscocho
J, Neahring L, Kwei KA, Qu K, Gong X, Ng T, Jones CD, et al:
Identification of recurrent SMO and BRAF mutations in
ameloblastomas. Nat Genet. 46:722–725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sugihara M, Morita H, Matsuda M,
Umebayashi H, Kajioka S, Ito S, Nishida M, Inoue R, Futatsuki T,
Yamazaki J, et al: Dual signaling pathways of arterial constriction
by extracellular uridine 5′-triphosphate in the rat. J Pharmacol
Sci. 115:293–308. 2011. View Article : Google Scholar
|
|
21
|
Kibe T, Fuchigami T, Kishida M, Iijima M,
Ishihata K, Hijioka H, Miyawaki A, Semba I, Nakamura N, Kiyono T,
et al: A novel ameloblastoma cell line (AM-3) secretes MMP-9 in
response to Wnt-3a and induces osteoclastogenesis. Oral Surg Oral
Med Oral Pathol Oral Radiol. 115:780–788. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsutsumi K, Matsuda M, Kotani M, Mizokami
A, Murakami A, Takahashi I, Terada Y, Kanematsu T, Fukami K,
Takenawa T, et al: Involvement of PRIP, phospholipase C-related,
but catalytically inactive protein, in bone formation. J Biol Chem.
286:31032–31042. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Loomer PM, Ellen RP and Tenenbaum HC:
Osteogenic and osteoclastic cell interaction: Development of a
co-culture system. Cell Tissue Res. 294:99–108. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thomas RJ, Guise TA, Yin JJ, Elliott J,
Horwood NJ, Martin TJ and Gillespie MT: Breast cancer cells
interact with osteoblasts to support osteoclast formation.
Endocrinology. 140:4451–4458. 1999.PubMed/NCBI
|
|
25
|
Michigami T, Ihara-Watanabe M, Yamazaki M
and Ozono K: Receptor activator of nuclear factor kappaB ligand
(RANKL) is a key molecule of osteoclast formation for bone
metastasis in a newly developed model of human neuroblastoma.
Cancer Res. 61:1637–1644. 2001.PubMed/NCBI
|
|
26
|
Blankenstein T: The role of tumor stroma
in the interaction between tumor and immune system. Curr Opin
Immunol. 17:180–186. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bhowmick NA and Moses HL: Tumor-stroma
interactions. Curr Opin Genet Dev. 15:97–101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Guzmán-Medrano R, Arreola-Rosales RL,
Shibayama M, Silva-Olivares DA, Bologna-Molina R and Rodríguez MA:
Tumor-associated macrophages and angiogenesis: A statistical
correlation that could reflect a critical relationship in
ameloblastoma. Pathol Res Pract. 208:672–676. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fuchigami T, Kibe T, Koyama H, Kishida S,
Iijima M, Nishizawa Y, Hijioka H, Fujii T, Ueda M, Nakamura N, et
al: Regulation of IL-6 and IL-8 production by reciprocal
cell-to-cell interactions between tumor cells and stromal
fibroblasts through IL-1α in ameloblastoma. Biochem Biophys Res
Commun. 451:491–496. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang HC, Jiang WP, Sima ZH and Li TJ:
Fibroblasts isolated from a keratocystic odontogenic tumor promote
osteoclastogenesis in vitro via interaction with epithelial cells.
Oral Dis. 21:170–177. 2015. View Article : Google Scholar
|
|
31
|
Kumamoto H and Ooya K: Expression of
parathyroid hormone-related protein (PTHrP), osteoclast
differentiation factor (ODF)/receptor activator of nuclear
factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory
factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas. J Oral
Pathol Med. 33:46–52. 2004. View Article : Google Scholar
|
|
32
|
da Silva TA, Batista AC, Mendonça EF,
Leles CR, Fukada S and Cunha FQ: Comparative expression of RANK,
RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas,
and dentigerous cysts. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 105:333–341. 2008. View Article : Google Scholar
|
|
33
|
Schramek D, Leibbrandt A, Sigl V, Kenner
L, Pospisilik JA, Lee HJ, Hanada R, Joshi PA, Aliprantis A,
Glimcher L, et al: Osteoclast differentiation factor RANKL controls
development of progestin-driven mammary cancer. Nature. 468:98–102.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gonzalez-Suarez E, Jacob AP, Jones J,
Miller R, Roudier-Meyer MP, Erwert R, Pinkas J, Branstetter D and
Dougall WC: RANK ligand mediates progestin-induced mammary
epithelial proliferation and carcinogenesis. Nature. 468:103–107.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Koga T, Inui M, Inoue K, Kim S, Suematsu
A, Kobayashi E, Iwata T, Ohnishi H, Matozaki T, Kodama T, et al:
Costimulatory signals mediated by the ITAM motif cooperate with
RANKL for bone homeostasis. Nature. 428:758–763. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Bradshaw JM: The Src, Syk, and Tec family
kinases: Distinct types of molecular switches. Cell Signal.
22:1175–1184. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Saltel F, Chabadel A, Zhao Y,
Lafage-Proust MH, Clézardin P, Jurdic P and Bonnelye E:
Transmigration: A new property of mature multinucleated
osteoclasts. J Bone Miner Res. 21:1913–1923. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Redlich K and Smolen JS: Inflammatory bone
loss: Pathogenesis and therapeutic intervention. Nat Rev Drug
Discov. 11:234–250. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hayashi M, Nakashima T, Taniguchi M,
Kodama T, Kumanogoh A and Takayanagi H: Osteoprotection by
semaphorin 3A. Nature. 485:69–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lai JY, Cox PJ, Patel R, Sadiq S, Aldous
DJ, Thurairatnam S, Smith K, Wheeler D, Jagpal S, Parveen S, et al:
Potent small molecule inhibitors of spleen tyrosine kinase (Syk).
Bioorg Med Chem Lett. 13:3111–3114. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Toyomura T, Oka T, Yamaguchi C, Wada Y and
Futai M: Three subunit a isoforms of mouse vacuolar
H+-ATPase. Preferential expression of the α3 isoform
during osteoclast differentiation. J Biol Chem. 275:8760–8765.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Toyomura T, Murata Y, Yamamoto A, Oka T,
Sun-Wada GH, Wada Y and Futai M: From lysosomes to the plasma
membrane: Localization of vacuolar-type H+-ATPase with
the α3 isoform during osteoclast differentiation. J Biol Chem.
278:22023–22030. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Forgac M: Vacuolar ATPases: Rotary proton
pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol.
8:917–929. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Matsumoto N, Daido S, Sun-Wada GH, Wada Y,
Futai M and Nakanishi-Matsui M: Diversity of proton pumps in
osteoclasts: V-ATPase with a3 and d2 isoforms is a major form in
osteoclasts. Biochim Biophys Acta. 1837:744–749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Frattini A, Orchard PJ, Sobacchi C,
Giliani S, Abinun M, Mattsson JP, Keeling DJ, Andersson AK,
Wallbrandt P, Zecca L, et al: Defects in TCIRG1 subunit of the
vacuolar proton pump are responsible for a subset of human
autosomal recessive osteopetrosis. Nat Genet. 25:343–346. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sobacchi C, Schulz A, Coxon FP, Villa A
and Helfrich MH: Osteopetrosis: Genetics, treatment and new
insights into osteoclast function. Nat Rev Endocrinol. 9:522–536.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jentsch TJ: Chloride and the
endosomal-lysosomal pathway: Emerging roles of CLC chloride
transporters. J Physiol. 578:633–640. 2007. View Article : Google Scholar
|
|
48
|
Zhang B, Zhang J, Huang HZ, Xu ZY and Xie
HL: Expression and role of metalloproteinase-2 and endogenous
tissue regulator in ameloblastoma. J Oral Pathol Med. 39:219–222.
2010. View Article : Google Scholar
|
